205
Participants
Start Date
April 22, 2016
Primary Completion Date
October 21, 2021
Study Completion Date
December 10, 2022
Electrochemotherapy (ECT)
Electrochemotherapy (ECT) is characterized by the association between the administration of a chemotherapic agent (Bleomycin) with the temporary raise of permeability of the cellular membrane induced by the local administration of electrical impulses (electroporation). ECT represents an effective therapy for loco-regional control of this disease.
Bleomycin
Electrochemotherapy (ECT) is characterized by the association between the administration of a chemotherapic agent (Bleomycin) with the temporary raise of permeability of the cellular membrane
Veneto Institute of Oncology IRCCS, Padua
Istituto Oncologico Veneto IRCCS
OTHER